Catalyst Pharmaceuticals (CPRX) EBT Margin Growth (3y) (2021 - 2026)
Catalyst Pharmaceuticals (CPRX) EBT Margin Growth (3y) (2021 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
EBT Margin Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
49,756.00 |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
441.00 |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Catalyst Pharmaceuticals |
3.84 Bn |
3.08 Bn |
134.92 Mn |
1,267.00 |
| Date | Value |
|---|
| Mar 31, 2026 |
1,267.00 |
| Dec 31, 2025 |
-721.00 |
| Sep 30, 2025 |
244.00 |
| Jun 30, 2025 |
-590.00 |
| Mar 31, 2025 |
989.00 |
| Dec 31, 2024 |
1,886.00 |
| Sep 30, 2024 |
531.00 |
| Jun 30, 2024 |
174.00 |
| Mar 31, 2024 |
-319.00 |
| Dec 31, 2023 |
1,411.00 |
| Sep 30, 2023 |
-7,706.00 |
| Jun 30, 2023 |
1,361.00 |
| Mar 31, 2023 |
583.00 |
| Dec 31, 2022 |
2,642.00 |
| Sep 30, 2022 |
-65.00 |
| Jun 30, 2022 |
1,361.00 |
| Mar 31, 2022 |
4,570.00 |
| Dec 31, 2021 |
293,337.00 |
